News for 'Sun Pharma'

SETL Invests Rs 500 Crore In AI Datacenter Sector With GScale Energy Acquisition

SETL Invests Rs 500 Crore In AI Datacenter Sector With GScale Energy Acquisition

Rediff.com25 Jun 2026

Hyderabad-based SETL, a precision engineering company, has acquired a 51% majority stake in GScale Energy Private Limited, an AI Datacenter Engineering infrastructure specialist. This strategic move involves an initial investment of Rs 190 crore, with a total commitment of Rs 500 crore, marking SETL's expansion into the rapidly growing AI Datacenter sector and leveraging its expertise from pharmaceutical and chemical industries.

Sensex gains nearly 790 points, driven by telecom and banking sector buying

Sensex gains nearly 790 points, driven by telecom and banking sector buying

Rediff.com14 May 2026

Indian stock markets saw a significant rebound, with the Sensex jumping nearly 790 points, primarily fuelled by strong buying interest in telecom, pharma, and private banking shares, despite a volatile trading session and a weakening rupee.

25 Year Old Building India's Spaceplane

25 Year Old Building India's Spaceplane

Rediff.com13 Jul 2026

'ISRO is planning to build a Bharatiya Antariksh Station by 2030. So, our goal is to create a vehicle that can supply modules to the Bharatiya Antariksh Station and bring the products back.'

India Inc Battles Rising Gulf War Costs

India Inc Battles Rising Gulf War Costs

Rediff.com9 Jun 2026

Companies are already diversifying sourcing, raising prices, and reworking operating models as the disruption drags on.

Stock Markets Today: Sensex, Nifty Surge on US-Iran Peace Deal, Low Oil Price

Stock Markets Today: Sensex, Nifty Surge on US-Iran Peace Deal, Low Oil Price

Rediff.com15 Jun 2026

Indian benchmark indices Sensex and Nifty surged significantly in early trade, mirroring a global rally and a sharp decline in crude oil prices following the finalisation of a peace deal between the US and Iran to end their 107-day conflict and reopen the Strait of Hormuz.

Mumbai businesswoman stripped, filmed at gunpoint in pharma firm office

Mumbai businesswoman stripped, filmed at gunpoint in pharma firm office

Rediff.com1 Dec 2025

As per the FIR, the woman was called to the company's office, where she was allegedly assaulted and stripped.

Sensex,Nifty Decline as US-Iran Tensions, FII Outflows Weigh on Sentiment

Sensex,Nifty Decline as US-Iran Tensions, FII Outflows Weigh on Sentiment

Rediff.com11 Jun 2026

Indian equity benchmark indices Sensex and Nifty closed lower on Thursday, driven by escalating tensions between the US and Iran, persistent foreign fund outflows, and concerns over rising US inflation.

Strong therapies, JB to lift Torrent Pharma

Strong therapies, JB to lift Torrent Pharma

Rediff.com18 Nov 2025

A strong performance in the July-September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of Torrent Pharmaceuticals.

Stock markets today: Sensex, Nifty rebound in early trade on blue-chip buying, Asian rally

Stock markets today: Sensex, Nifty rebound in early trade on blue-chip buying, Asian rally

Rediff.com1 Jun 2026

Indian benchmark indices Sensex and Nifty rebounded in early trade, driven by strong buying in blue-chip stocks and positive cues from Asian markets, following a significant selloff in the previous session.

Indian Equities Bounce Back: Sensex Jumps 639 Pts, Nifty Up 194 Pts

Indian Equities Bounce Back: Sensex Jumps 639 Pts, Nifty Up 194 Pts

Rediff.com27 Apr 2026

Indian benchmark stock indices Sensex and Nifty rebounded nearly 1 per cent, snapping a three-day decline, driven by rallies in Reliance Industries and Sun Pharma, alongside positive global market trends and easing geopolitical tensions.

How India Can Create 100 Million New Jobs In 7 Years!

How India Can Create 100 Million New Jobs In 7 Years!

Rediff.com4 Jun 2026

TeamLease Co-founder Manish Sabharwal on why regulatory cholesterol is killing India's entrepreneurial engine -- and how we can fix it and generate 100 million jobs in India in just about 7 years.

Drug Trafficker Dola's Chemist Links Under Investigation

Drug Trafficker Dola's Chemist Links Under Investigation

Rediff.com3 May 2026

Investigators are probing the network of Mohammad Salim Dola, an alleged international drug trafficker, and have uncovered links with chemists and pharma dealers who allegedly aided his illicit trans-national racket.

Stock markets today: Sensex, Nifty slump on global cues

Stock markets today: Sensex, Nifty slump on global cues

Rediff.com8 Jun 2026

Indian benchmark indices Sensex and Nifty experienced a significant slump in early trade, mirroring a sharp decline in global equities and a fresh spike in crude oil prices, exacerbated by simmering tensions in West Asia and a global unwinding of the AI-led rally. Track how sensex, Nifty fared on June 8.

High Crude Prices, Global Cues Drag Indian Stock Markets Lower

High Crude Prices, Global Cues Drag Indian Stock Markets Lower

Rediff.com30 Apr 2026

Indian benchmark stock indices, Sensex and Nifty, closed nearly 1 per cent lower due to surging crude oil prices, weak global market trends, and significant foreign fund outflows, with geopolitical tensions and inflation concerns further dampening investor sentiment.

Pharma owner arrested over cough syrup that killed 20 children

Pharma owner arrested over cough syrup that killed 20 children

Rediff.com9 Oct 2025

S Ranganathan, the owner of the Tamil Nadu-based pharmaceuticals company that manufactured the Coldrif cough syrup linked to 20 children's deaths, has been arrested.

Stock markets today: Sensex, Nifty turn flat after falling in early trade

Stock markets today: Sensex, Nifty turn flat after falling in early trade

Rediff.com26 May 2026

The BSE benchmark traded 44.43 points up at 76,521.93, and the Nifty quoted 17.20 points higher at 24,048.85. Track Stock markets on May 26.

Agilisium invests in AI to transform pharma, biotech and medical tech companies

Agilisium invests in AI to transform pharma, biotech and medical tech companies

Rediff.com18 Mar 2026

Agilisium has invested Rs 50 crore to help pharmaceutical, biotech, and medical technology companies operationalise artificial intelligence, introducing a new professional standard called Forward Deployment Experts (FDX).

Indian Equities Rally: Banks Lead as Global Trends Boost Market Sentiment

Indian Equities Rally: Banks Lead as Global Trends Boost Market Sentiment

Rediff.com22 May 2026

Indian stock market benchmark indices closed higher, driven by strong performance in blue-chip bank shares and a positive trend in global markets, with hopes of progress in US-Iran peace negotiations also contributing to optimism.

Stock Markets Today: Sensex, Nifty Surge as Global Markets Rally, Oil Price Eases

Stock Markets Today: Sensex, Nifty Surge as Global Markets Rally, Oil Price Eases

Rediff.com21 May 2026

Indian benchmark equity indices, Sensex and Nifty, opened higher, tracking positive global trends and easing crude oil prices, fueled by hopes of a swift resolution to the West Asia conflict. Track Nifty 50 and BSE Sensex performance and key global triggers.

Stock Markets Surge as Crude Oil Dips Below $100 Amid US-Iran Deal Hopes

Stock Markets Surge as Crude Oil Dips Below $100 Amid US-Iran Deal Hopes

Rediff.com25 May 2026

Indian benchmark equity indices Sensex and Nifty surged in early trade, driven by a sharp correction in crude oil prices below USD 100 per barrel and a rally in global markets, fuelled by improving sentiment surrounding US-Iran negotiations.

Sensex, Nifty Surge Over 1% as Crude Oil Drops Below $100/Barrel on US-Iran Deal Hopes

Sensex, Nifty Surge Over 1% as Crude Oil Drops Below $100/Barrel on US-Iran Deal Hopes

Rediff.com25 May 2026

Indian benchmark equity indices, Sensex and Nifty, surged over 1 per cent, driven by a significant correction in crude oil prices and a global market rally, fueled by improving sentiment surrounding potential US-Iran negotiations.

Diagnostics sector poised for robust Q4 growth, outperforming healthcare peers

Diagnostics sector poised for robust Q4 growth, outperforming healthcare peers

Rediff.com20 Apr 2026

The diagnostics sector is projected to significantly outperform other healthcare segments like pharmaceuticals and hospitals in Q4FY26, driven by increasing volumes, stable realisations, and a domestic focus that insulates it from geopolitical risks.

US tariffs: Only Sun Pharma exposed to some headline risk

US tariffs: Only Sun Pharma exposed to some headline risk

Rediff.com28 Sep 2025

The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report.

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Rediff.com8 Jan 2026

The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025. Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.

Couple Banned from UK Companies for Breaching Disqualification Order

Couple Banned from UK Companies for Breaching Disqualification Order

Rediff.com5 Apr 2026

An Indian-origin couple in the UK has been sentenced for breaching a disqualification order, operating companies despite a ban imposed after tax fraud claims.

Smallcap Schemes Lead Mutual Fund Rally

Smallcap Schemes Lead Mutual Fund Rally

Rediff.com1 Jun 2026

Most actively-managed equity mutual fund schemes outperformed their benchmarks despite volatility across domestic equity markets during the past year.

Indian Equities Snap Losing Streak, End Marginally Higher

Indian Equities Snap Losing Streak, End Marginally Higher

Rediff.com13 May 2026

Indian benchmark equity indices, Sensex and Nifty, closed marginally higher, breaking a four-day losing streak, despite elevated crude oil prices and ongoing geopolitical uncertainties. The market saw a temporary pause in panic selling, though cautious sentiment persists.

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

Tax changes sweeten the deal, making share buybacks attractive for Indian companies

Tax changes sweeten the deal, making share buybacks attractive for Indian companies

Rediff.com5 May 2026

Indian companies are increasingly turning to share buybacks as a preferred payout strategy, driven by recent tax framework changes that make them more tax-efficient for non-promoter shareholders and a fall in stock prices.

Stock Markets Edge Higher, IT Sector Shines Amid Volatility

Stock Markets Edge Higher, IT Sector Shines Amid Volatility

Rediff.com18 May 2026

Indian benchmark indices, Sensex and Nifty, closed marginally higher after a volatile trading session, driven by value buying in IT and select blue-chip counters, despite global crude price hikes and a weak rupee.

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Rediff.com5 Nov 2025

Sun Pharmaceutical Industries on Wednesday posted a 2.56 per cent increase in its consolidated net profit to Rs 3,118 crore for the second quarter ended September 30, aided by robust sales in India and emerging markets. The Mumbai-based drug major reported a net profit of Rs 3,040 crore for the July-September quarter of the last fiscal.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

Massive Fake Degree Racket Uncovered In Kanpur

Massive Fake Degree Racket Uncovered In Kanpur

Rediff.com18 May 2026

Kanpur police have exposed a large-scale fake degree racket, arresting two individuals allegedly involved in supplying forged educational documents across multiple states. The operation uncovered fake marksheets, migration certificates, and degrees from various universities, raising concerns about the integrity of academic credentials and potential implications for employment and admissions.

Stock Markets Today: Sensex, Nifty50 Rally as US-Iran Tensions Ease

Stock Markets Today: Sensex, Nifty50 Rally as US-Iran Tensions Ease

Rediff.com16 Apr 2026

Indian markets on Dalal Street rallied sharply as easing tensions in the US-Iran conflict and stable oil prices boosted sentiment. Track Nifty50 and BSE Sensex performance and key global triggers.

India's West Asia Trade Contracts for Second Month Amid Shipping Disruptions

India's West Asia Trade Contracts for Second Month Amid Shipping Disruptions

Rediff.com15 May 2026

India's trade with West Asia saw a significant decline of over 28% in April, marking the second consecutive month of contraction. This downturn is attributed to severe shipping disruptions stemming from the ongoing conflict involving the US, Israel, and Iran, particularly impacting the crucial Strait of Hormuz waterway.

Indian Equities Close Lower as Geopolitical Tensions, FII Outflows Weigh

Indian Equities Close Lower as Geopolitical Tensions, FII Outflows Weigh

Rediff.com7 May 2026

Indian benchmark indices, Sensex and Nifty, ended lower in choppy trade, with the Sensex declining 114 points, as investors reacted to unabated foreign fund outflows and rising geopolitical uncertainties.

Search Launched For Missing Student In Uttar Pradesh

Search Launched For Missing Student In Uttar Pradesh

Rediff.com8 May 2026

A 24-year-old student, who is also the nephew of a BJP MLA, has gone missing from a medical college in Bareilly, Uttar Pradesh, prompting a police investigation.

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Rediff.com12 Aug 2025

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.